NOVN.CH

101.18

-0.59%↓

LONN.CH

568.8

-0.8%↓

BANB.CH

64.2

-0.23%↓

NOVN.CH

101.18

-0.59%↓

LONN.CH

568.8

-0.8%↓

BANB.CH

64.2

-0.23%↓

NOVN.CH

101.18

-0.59%↓

LONN.CH

568.8

-0.8%↓

BANB.CH

64.2

-0.23%↓

NOVN.CH

101.18

-0.59%↓

LONN.CH

568.8

-0.8%↓

BANB.CH

64.2

-0.23%↓

NOVN.CH

101.18

-0.59%↓

LONN.CH

568.8

-0.8%↓

BANB.CH

64.2

-0.23%↓

Начало・Списък с акции・Roche Holding AG

Roche Holding AG

Отворен

СекторЗдравеопазване

274.6 -0.15

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

267.2

Максимум

276.4

Ключови измерители
By Trading Economics
Приходи	5.8B 7.8B
Продажби	297M 31B
P/E Средно за сектора	23.169 35.724
Дивидентна доходност	3.55
Марж на печалбата	25.31
Служители	103,249
EBITDA	6B

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	3.55% 3.09%

Пазарни показатели
By TradingEconomics
Пазарна капитализация	2.7B 208B
Предишно отваряне	274.75
Предишно затваряне	274.6

Настроения в новините

By Acuity

50%

172 / 372 Класиране в Healthcare

Roche Holding AG Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.07.2025 г., 15:09 ч. UTC

Печалби

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24.07.2025 г., 05:36 ч. UTC

Печалби

Roche Backs 2025 Views After Strong Sales of Key Drugs

11.06.2025 г., 08:25 ч. UTC

Придобивния, сливания и поглъщания

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12.05.2025 г., 02:16 ч. UTC

Значими двигатели на пазара

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24.04.2025 г., 07:30 ч. UTC

Печалби

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24.04.2025 г., 05:31 ч. UTC

Печалби

Roche Sales Rise Boosted By Key Drugs

8.08.2025 г., 10:51 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

8.08.2025 г., 07:39 ч. UTC

Пазарно говорене

Печалби

Roche Could Reach Peak Earnings Growth This Year -- Market Talk

5.08.2025 г., 10:40 ч. UTC

Пазарно говорене

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24.07.2025 г., 06:52 ч. UTC

Пазарно говорене

Печалби

Roche Looks Confident in a Tricky Environment -- Market Talk

24.07.2025 г., 05:05 ч. UTC

Печалби

Roche Backs 2025 View

24.07.2025 г., 05:05 ч. UTC

Печалби

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24.07.2025 г., 05:04 ч. UTC

Печалби

Correct: Roche 1H Sales Rose 4% On Year , Reported

24.07.2025 г., 05:04 ч. UTC

Печалби

Roche 1H Net Pft Was Seen at CHF8.4B

24.07.2025 г., 05:04 ч. UTC

Печалби

Roche 1H Net Pft CHF7.8B

24.07.2025 г., 05:03 ч. UTC

Печалби

Roche 1H Oper Pft CHF12.0B

24.07.2025 г., 05:03 ч. UTC

Печалби

Roche 1H Diagnostics Sales Down 3% at Constant Currency

24.07.2025 г., 05:03 ч. UTC

Печалби

Roche 1H Sales Rose 4% On Year at Constant Currency

24.07.2025 г., 05:02 ч. UTC

Печалби

Roche 1H Sales CHF30.9B , In Line With Analyst Views

21.07.2025 г., 06:44 ч. UTC

Пазарно говорене

Roche Drug Candidate Disappoints in Lung Disease Trials -- Market Talk

16.06.2025 г., 08:55 ч. UTC

Горещи акции

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3.06.2025 г., 07:51 ч. UTC

Пазарно говорене

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21.05.2025 г., 07:20 ч. UTC

Пазарно говорене

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2.05.2025 г., 06:25 ч. UTC

Пазарно говорене

Печалби

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24.04.2025 г., 09:39 ч. UTC

Пазарно говорене

Печалби

Roche's Pipeline in Focus After Solid Results -- Market Talk

24.04.2025 г., 09:24 ч. UTC

Пазарно говорене

Печалби

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24.04.2025 г., 09:18 ч. UTC

Пазарно говорене

Печалби

Roche's Results Are Solid -- Market Talk

24.04.2025 г., 05:16 ч. UTC

Топ новини

Roche Sales Rise, Boosted By Key Drugs

22.04.2025 г., 10:51 ч. UTC

Топ новини

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15.04.2025 г., 09:55 ч. UTC

Пазарно говорене

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Roche Holding AG Прогноза

Настроение

By Acuity

172 / 372 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.